Research ArticleOriginal Article

Identification of portal vein tumor thrombus with an independent clonal origin in hepatocellular carcinoma via multi-omics data analysis

Shupeng Liu, Zaixin Zhou, Yin Jia, Jie Xue, Zhiyong Liu, Kai Cheng, Shuqun Cheng and Shanrong Liu
Cancer Biology & Medicine February 2019, 16 (1) 147-170; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0184

References

  1. 1.↵
    2. Zhang ZM,
    3. Lai ECH,
    4. Zhang C,
    5. Yu HW,
    6. Liu Z,
    7. Wan BJ, et al.
    The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus. Int J Surg. 2015; 20: 8–16.
    OpenUrl
  2. 2.↵
    2. Kokudo T,
    3. Hasegawa K,
    4. Matsuyama Y,
    5. Takayama T,
    6. Izumi N,
    7. Kadoya M, et al.
    Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion. J Hepatol. 2016; 65: 938–43.
    OpenUrlCrossRefPubMed
  3. 3.↵
    2. Sakamoto K,
    3. Nagano H.
    Surgical treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus. Hepatol Res. 2017; 47: 957–62.
    OpenUrl
  4. 4.↵
    2. Bruix J,
    3. Sherman M.
    Management of hepatocellular carcinoma: an update. Hepatology. 2011; 53: 1020–2.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    2. Cheng SQ,
    3. Chen MS,
    4. Cai JQ,
    National Research Cooperative Group for Diagnosis, Treatment of Hepatocellular Carcinoma with Tumor Thrombus. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition. Oncotarget. 2017; 8: 8867–76.
    OpenUrl
  6. 6.↵
    2. Tang YF,
    3. Liu SP,
    4. Li N,
    5. Guo WX,
    6. Shi J,
    7. Yu HM, et al.
    14-3-3ζ promotes hepatocellular carcinoma venous metastasis by modulating hypoxia-inducible factor-1α. Oncotarget. 2016; 7: 15854–67.
    OpenUrl
  7. 7.↵
    2. Ye LY,
    3. Chen W,
    4. Bai XL,
    5. Xu XY,
    6. Zhang Q,
    7. Xia XF, et al.
    Hypoxia-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma induces an immunosuppressive tumor microenvironment to promote metastasis. Cancer Res. 2016; 76: 818–30.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    2. Zhang J,
    3. Pan YF,
    4. Ding ZW,
    5. Yang GZ,
    6. Tan YX,
    7. Yang C, et al.
    Rmp promotes venous metastases of hepatocellular carcinoma through promoting il-6 transcription. Oncogene. 2015; 34: 1575–83.
    OpenUrlCrossRefPubMed
  9. 9.↵
    2. Guo WX,
    3. Liu SP,
    4. Cheng YQ,
    5. Lu L,
    6. Shi J,
    7. Xu GX, et al.
    ICAM-1-related noncoding rna in cancer stem cells maintains ICAM-1 expression in hepatocellular carcinoma. Clin Cancer Res. 2015; 22: 2041–50.
    OpenUrl
  10. 10.↵
    2. Ye QH,
    3. Qin LX,
    4. Forgues M,
    5. He P,
    6. Kim JW,
    7. Peng AC, et al.
    Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med. 2003; 9: 416–23.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    2. Yang Y,
    3. Chen L,
    4. Gu J,
    5. Zhang HS,
    6. Yuan JP,
    7. Lian QY, et al.
    Recurrently deregulated lncRNAs in hepatocellular carcinoma. Nat Commun. 2017; 8: 14421.
    OpenUrl
  12. 12.↵
    2. Guo WX,
    3. Xue J,
    4. Shi J,
    5. Li N,
    6. Shao Y,
    7. Yu XY, et al.
    Proteomics analysis of distinct portal vein tumor thrombi in hepatocellular carcinoma patients. J Proteome Res. 2010; 9: 4170–5.
    OpenUrlPubMed
  13. 13.↵
    2. Saito M,
    3. Seo Y,
    4. Yano Y,
    5. Uehara K,
    6. Hara S,
    7. Momose K, et al.
    Portal venous tumor growth-type of hepatocellular carcinoma without liver parenchyma tumor nodules: a case report. Ann Hepatol. 2013; 12: 969–73.
    OpenUrlPubMed
  14. 14.↵
    2. Zhang H,
    3. Ye JY,
    4. Weng XL,
    5. Liu FT,
    6. He L,
    7. Zhou DZ, et al.
    Comparative transcriptome analysis reveals that the extracellular matrix receptor interaction contributes to the venous metastases of hepatocellular carcinoma. Cancer Genet. 2015; 208: 482–91.
    OpenUrlCrossRef
  15. 15.↵
    2. Nemes S,
    3. Danielsson A,
    4. Parris TZ,
    5. Jonasson JM,
    6. Bülow E,
    7. Karlsson P, et al.
    A diagnostic algorithm to identify paired tumors with clonal origin. Genes Chromosomes Cancer. 2013; 52: 1007–16.
    OpenUrl
  16. 16.↵
    2. Haffner MC,
    3. Mosbruger T,
    4. Esopi DM,
    5. Fedor H,
    6. Heaphy CM,
    7. Walker DA, et al.
    Tracking the clonal origin of lethal prostate cancer. J Clin Invest. 2013; 123: 4918–22.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    2. Tripathi S,
    3. Pohl MO,
    4. Zhou YY,
    5. Rodriguez-Frandsen A,
    6. Wang GJ,
    7. Stein DA, et al.
    Meta- and orthogonal integration of influenza "OMICs" data defines a role for UBR4 in virus budding. Cell Host Microbe. 2015; 18: 723–35.
    OpenUrlCrossRefPubMed
  18. 18.↵
    2. Reich M,
    3. Liefeld T,
    4. Gould J,
    5. Lerner J,
    6. Tamayo P,
    7. Mesirov JP.
    Genepattern 2.0. Nat Genet. 2006; 38: 500–1.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    2. Ceulemans A,
    3. Verhulst S,
    4. Van Haele M,
    5. Govaere O,
    6. Ventura JJ,
    7. Van Grunsven LA, et al.
    Rna-sequencing-based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers. Cell Death Dis. 2017; 8: e3164.
  20. 20.↵
    2. Hoshida Y,
    3. Nijman SMB,
    4. Kobayashi M,
    5. Chan JA,
    6. Brunet JP,
    7. Chiang DY, et al.
    Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res. 2009; 69: 7385–92.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    2. Sia D,
    3. Jiao Y,
    4. Martinez-Quetglas I,
    5. Kuchuk O,
    6. Villacorta-Martin C,
    7. Castro De Moura M, et al.
    Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features. Gastroenterology. 2017; 153: 812–26.
    OpenUrlCrossRefPubMed
  22. 22.↵
    2. Song FF,
    3. Li XC,
    4. Song FJ,
    5. Zhao YR,
    6. Li HX,
    7. Zheng H, et al.
    Comparative genomic analysis reveals bilateral breast cancers are genetically independent. Oncotarget. 2015; 6: 31820–9.
    OpenUrl
  23. 23.↵
    2. Venkatraman ES,
    3. Olshen AB.
    A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics. 2007; 23: 657–63.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    2. Sia D,
    3. Villanueva A,
    4. Friedman SL,
    5. Llovet JM.
    Liver cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology. 2017; 152: 745–61.
    OpenUrlCrossRefPubMed
  25. 25.↵
    2. Turner KM,
    3. Deshpande V,
    4. Beyter D,
    5. Koga T,
    6. Rusert J,
    7. Lee C, et al.
    Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. Nature. 2017; 543: 122–5.
    OpenUrlCrossRefPubMed
  26. 26.↵
    2. Hanahan D,
    3. Weinberg RA.
    Hallmarks of cancer: the next generation. Cell. 2011; 144: 646–74.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    2. Wang M,
    3. Xi D,
    4. Ning Q.
    Virus-induced hepatocellular carcinoma with special emphasis on HBV. Hepatol Int. 2017; 11: 171–80.
    OpenUrl
  28. 28.↵
    2. Tomczak K,
    3. Czerwińska P,
    4. Wiznerowicz M.
    The cancer genome atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol. 2015; 19: A68–77.
    OpenUrlCrossRefPubMed
  29. 29.↵
    The Cancer Genome Atlas Research Network. Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell. 2017; 169: 1327–1341.e23.
    OpenUrlCrossRefPubMed
  30. 30.↵
    2. Hoadley KA,
    3. Yau C,
    4. Wolf DM,
    5. Cherniack AD,
    6. Tamborero D,
    7. Ng S, et al.
    Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell. 2014; 158: 929–44.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords